Analyst Ratings for Arch Therapeutics (ARTH)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
10/30/2023 | Dawson James | Jason Kolbert | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.60 (1.14) |
90% | Details |
3/14/2018 | IFS Securities | N/A | Downgrade | Outperform (Strong Buy) |
1.85 (N/A) |
0.31 (1.14) |
267.74% | Details |